Starget Pharma Secures $18 Million Series A Funding to Enhance Cancer Therapy Development Starget Pharma Inc. has closed an $18 million Series A funding round and partnered with CMIT to advance innovative cancer therapies using AI technology.

Starget Pharma Secures $18 Million Series A Funding to Enhance Cancer Therapy Development #United_States #Shreveport #Cancer_Innovation #Starget_Pharma #CMIT